Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

Up to 30% of people with migraines experience an aura phase, a sensation characterized by visual or sensory disturbances such ...

Migraine Is a Brain Disease Although the pathogenesis of migraine — or how the disease develops — is not completely clear, it’s believed to be caused by a complex interaction among your genes, the ...

SAN DIEGO — Migraine is the third most common neurological disorder worldwide, and yet reliable treatments remain elusive. Research hinting at new avenues for treatments will be presented at ...

Migraine is a chronic and debilitating neurological condition affecting women 3 to 4 more times than men. Despite an estimated 1.1 billion people being impacted by the condition, the physiological ...

Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...

The EMA has endorsed Aquipta, an oral CGRP receptor antagonist, after it showed superior pain relief vs placebo in treating migraine attacks in adults.